Skip to content

Merck’s Covid Pill Comes With Warning to Avoid in Pregnancy

  • FDA authorization follows nod for Pfizer drug on Wednesday
  • Treatments offer hope of staving off surge in hospitalizations
Video player cover image
Merck Covid Pill Cleared by FDA
Updated on

Merck & Co.’s Covid-19 pill was cleared by U.S. regulators Thursday, giving high-risk patients a second at-home treatment just as the omicron variant is causing cases to surge around the country.

The drug, molnupiravir, received emergency authorization on the heels of Pfizer Inc.’s Covid pill being cleared Wednesday. The FDA said Merck’s drug is not recommended for use in pregnant people.